We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Stockholm, Sweden

ESTRO 2026

Session

Monday
May 18
17:00 - 18:00
A6
Brain tumours & gynaecological malignancies
Selma Ben Mustapha, Belgium
Mini-Orals
Clinical
17:00 - 18:00
Dose escalation with intensity-modulated proton therapy for high-risk meningiomas – Results from a phase 1 trial
Felix Ehret, Germany
-1755
17:00 - 18:00
Association Between Perceived Stress, Physical Activity, and Fatigue in Glioblastoma Patients: Results from a Prospective Study (NCT05431348)
Catharina M.L. Zegers, The Netherlands
-2843
17:00 - 18:00
Neoadjuvant ultrahypofractionated radiotherapy with simultaneous integrated boost for Glioblastoma.
Miriam Torrisi, Italy
-3130
17:00 - 18:00
Hypo- vs normofractionated radiotherapy in patients under 70 with biopsied or incompletely resected glioblastoma : a retrospective multicentre study
Celine Chevreau, France
-2663
17:00 - 18:00
Quality of Life Analysis of a Phase II randomised controlled trial evaluating adjuvant pelvic radiotherapy using IMRT or 3DRT for endometrial Cancer
Darragh Browne, Ireland
-3327
17:00 - 18:00
Sexual dysfunction in cervix cancer survivors after surgery and/or radiochemotherapy: a Bayesian network analysis based on the SENECA study cohort
Adriel Ngo, Canada
-4872
17:00 - 18:00
Prospective Observational Study Comparing Late Adverse Events and Survival Outcomes in HIV Positive and Negative Cervical Cancer Patients in India
Supriya Chopra, India
-1819